Authors: Suzanne Elvidge , Dr. Oded Ben-Joseph (contributing author)
Navigating uncharted waters, biotech investors, executives and entrepreneurs are finding unique challenges (and opportunities) in a COVID-19 world. Contributing author, Outcome Capital’s Dr. Oded Ben-Joseph, Managing Director and Co-Founder of the Life Sciences Practice.
November 12, 2021 10:48 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a specialized life sciences and healthcare advisory and investment banking firm, today announced that Getinge has acquired Verrix LLC. Outcome Capital served as the exclusive strategic and financial advisor to Verrix. “There is a growing demand for biological indicators from healthcare institutions around the […]Read More
September 13, 2021 Vancouver, British Columbia & Boston, MA. AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced it has acquired TetraGenetics, Inc. (TetraGenetics), a biotechnology company with a proprietary platform for generating recombinant human ion channels and other transmembrane proteins, in an all-cash transaction that includes […]Read More
Outcome Capital Life Science Market Pulse October 2021 Click to view our LifeSciences Pulse NewsletterDownload